TrialNaunyn-Schmiedeberg's archives of pharmacology2024

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel kappa opioid receptor agonist ZYKR1: a randomized double-blind placebo-control phase 1 study in healthy adult human participants.

Kevinkumar A Kansagra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.